Abstract:An ICD and pyroptosis‐induced nanoenzyme is first proposed for efficient tumor immunotherapy. The nanoenzyme IMZF demonstrates the SOD, CAT, POD, and GSHOx‐like catalytic ability; then thus, facilitating ROS generation, depleting GSH, and arousing ICD/pyroptosis pathways for efficient antigen presentation. This work provides a new design strategy for simultaneously enhancing antigen presentation and for reversal of immune suppression TME. Immunotherapy represents a widely employed modality in clinical oncology, leveraging the activation of the human immune system to target and eradicate cancer cells and tumor tissues via endogenous immune mechanisms. However, its efficacy remains constrained by inadequate immune responses within "cold" tumor microenvironment (TME). In this study, a multifunctional nanoscale pyroptosis inducer with cascade enzymatic activity (IMZF), comprising superoxide dismutase (SOD), catalase (CAT), peroxidase (POD), and glutathione oxidase (GSHOx), is dissociated within the acidic and glutathione‐rich TME. The vigorous enzymatic activity not only generates oxygen (O2) to alleviate hypoxia and promote M2 to M1 macrophage polarization but also yields reactive oxygen species (ROS) and depletes glutathione (GSH) within the TME. Functioning as an immunogenic cell death (ICD) activator and pyroptosis inducer, IMZF synergistically triggers dendritic cell maturation and inflammatory lymphocyte infiltration via ICD‐associated pyroptosis, thereby reversing immune suppression within the TMEs. Consequently, it exerts inhibitory effects on both primary and distal tumors. This cascade enzymatic platform‐based pyroptosis inducer offers an intelligent strategy for effectively overcoming immune suppression within "cold" tumors, thereby providing a promising avenue for advanced immunotherapeutic interventions.

ROS Scavenging Nanozyme Modulates Immunosuppression for Sensitized Cancer Immunotherapy (Adv. Healthcare Mater. 21/2023)

ROS Scavenging Nanozyme Modulates Immunosuppression for Sensitized Cancer Immunotherapy

Nanozymes for Catalytic Cancer Immunotherapy

Unraveling Ros Conversion Through Enhanced Enzyme‐Like Activity with Copper‐Doped Cerium Oxide for Tumor Nanocatalytic Therapy

Augmenting Immunotherapy via Bioinspired MOF-Based ROS Homeostasis Disruptor with Nanozyme-Cascade Reaction

ROS scavenging Mn3O4 nanozymes for in vivo anti-inflammation.

Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD‐L1 for Enhanced Cancer Immunotherapy (Adv. Mater. 22/2023)

Flower‐Like Nanozymes with Large Accessibility of Single Atom Catalysis Sites for ROS Generation Boosted Tumor Therapy

Zinc-Based ROS Amplifiers Trigger Cancer Chemodynamic/Ion Interference Therapy Through Self-Cascade Catalysis

Precise Regulation of Reactive Oxygen Species in Tumor Microenvironment for Alleviating Inhibitory Immunogenic Cell Death

Nanozymes as Glucose Scavengers and Oxygenerators for Enhancing Tumor Radiotherapy

Mesoporous cerium oxide nanoenzyme for Efficacious impeding tumor and metastasis via Conferring resistance to anoikis

Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases

Programmed Nanoreactors Boost Immune Response through ROS Cascade Amplification along with RNS Storm

Advances in Anti-tumor Application of ROS Enzymatic-mimetic Catalysts

Precise modulation and use of reactive oxygen species for immunotherapy

Nanozymes Regulate Redox Homeostasis in ROS-Related Inflammation

Nanoscale Dual-Enzyme Cascade Metal-Organic Frameworks Through Biomimetic Mineralization As ROS Generators for Synergistic Cancer Therapy.

Multi‐Enzyme Nanoparticles as Efficient Pyroptosis and Immunogenic Cell Death Inducers for Cancer Immunotherapy

Self-assembling gelatin based delivery of multienzyme activity nanozyme and photosensitizer for ROS storm based cancer therapy

Self‐Oxygenated Biomimetic Nanozyme for Tumor Catalytic Immunotherapy